» Articles » PMID: 30506614

HIV, HCMV and Mycobacterial Antibody Levels: a Cross-sectional Study in a Rural Ugandan Cohort

Overview
Date 2018 Dec 4
PMID 30506614
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A growing evidence base implicates human cytomegalovirus (HCMV) as a risk factor for TB disease. We investigated total IgG and mycobacteria-specific antibodies in a cross-sectional study nested within a rural Ugandan General Population Cohort (GPC), in relation to HIV infection and the magnitude of HCMV IgG response.

Methods: Sera from 2189 individuals (including 27 sputum-positive TB cases) were analysed for antibodies against mycobacteria (Ag85A, PPD, LAM, ESAT6/CFP10) and HCMV, tetanus toxoid (TT) and total IgG.

Results: Anti-mycobacterial antibodies increased with age until approximately 20 years, when they plateaued. Higher HCMV exposure (measured by IgG) was associated with lower levels of some anti-mycobacterial antibodies, but no increase in total IgG. HIV infection was associated with a decrease in all anti-mycobacterial antibodies measured and with an increase in total IgG.

Conclusions: The increase in anti-mycobacterial antibodies with age suggests increasing exposure to non-tuberculous mycobacteria (NTM), and to M.tb itself. HIV infection is associated with decreased levels of all mycobacterial antibodies studied here, and high levels of HCMV IgG are associated with decreased levels of some mycobacterial antibodies. These findings point towards the importance of humoral immune responses in HIV/TB co-infection and highlight a possible role of HCMV as a risk factor for TB disease.

Citing Articles

Human Cytomegalovirus Immunoglobulin G Response and Pulmonary Tuberculosis in Adolescents: A Case-Control Study.

Swanepoel J, van Zyl G, Hesseling A, Johnson S, Moore D, Seddon J Open Forum Infect Dis. 2023; 10(11):ofad487.

PMID: 37937044 PMC: 10627337. DOI: 10.1093/ofid/ofad487.


NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.

Wagstaffe H, Anzala O, Kibuuka H, Anywaine Z, Sirima S, Thiebaut R Vaccines (Basel). 2022; 10(6).

PMID: 35746491 PMC: 9230153. DOI: 10.3390/vaccines10060884.


Association Between Cytomegalovirus Infection and Tuberculosis Disease: A Systematic Review and Meta-Analysis of Epidemiological Studies.

Kua K, Chongmelaxme B, Lee S J Infect Dis. 2022; 227(4):471-482.

PMID: 35512129 PMC: 9927079. DOI: 10.1093/infdis/jiac179.


Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.

Olbrich L, Stockdale L, Roy R, Song R, Cicin-Sain L, Whittaker E PLoS Pathog. 2021; 17(12):e1010061.

PMID: 34882748 PMC: 8659711. DOI: 10.1371/journal.ppat.1010061.


Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.

Muller J, Tanner R, Matsumiya M, Snowden M, Landry B, Satti I JCI Insight. 2019; 4(23).

PMID: 31697647 PMC: 6962026. DOI: 10.1172/jci.insight.130090.

References
1.
Tameris M, Hatherill M, Landry B, Scriba T, Snowden M, Lockhart S . Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013; 381(9871):1021-8. PMC: 5424647. DOI: 10.1016/S0140-6736(13)60177-4. View

2.
Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave E . Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010; 207(13):2869-81. PMC: 3005236. DOI: 10.1084/jem.20100090. View

3.
Sirenko I, Shmatko S, Smelianskaia M, Peremot S, Marchenko O, Podoprigora N . [Impact of cytomegalovirus infection on the course of tuberculosis in children and adolescents]. Probl Tuberk Bolezn Legk. 2003; (8):7-9. View

4.
Dauby N, Kummert C, Lecomte S, Liesnard C, Delforge M, Donner C . Primary human cytomegalovirus infection induces the expansion of virus-specific activated and atypical memory B cells. J Infect Dis. 2014; 210(8):1275-85. DOI: 10.1093/infdis/jiu255. View

5.
Mehta S, Stowe R, Feiveson A, Tyring S, Pierson D . Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis. 2000; 182(6):1761-4. DOI: 10.1086/317624. View